P., Urick, B
When someone needs to stay on a psychiatric medication thats working for their mental health but is causing problematic weight gain, adding a low-dose GLP-1 might allow them to maintain their psychiatric stability while addressing the metabolic consequences
Anthem typically follows FDA label criteria: BMI 30 (obesity) or BMI 27 with at least one weight-related comorbidity such as type 2 diabetes, hypertension (high blood pressure), high cholesterol, or obstructive sleep apnea
If you take BPC-157 via an injection, you may get: Itchiness, pain, or numbness at the injection site Vein, muscle, or skin discomfort Higher blood pressure Increased water retention Unintentional weight gain/loss Tiredness Who Can Benefit From BPC-157
In 2025, the estimated global market size for this category of pharmaceuticals was $66 billion
Additional data are made available in supplementary data of this manuscript